Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model.

Article English OPEN
Cid Ruzafa, J; Merinopoulou, E; Baggaley, RF; Leighton, P; Werther, W; Felici, D; Cox, A;
  • Publisher: Wiley

Multiple myeloma (MM) is a progressive, malignant neoplasia with a worldwide, age-standardized annual incidence of 1.5 per 100 000 individuals and 5-year prevalence around 230 000 patients. Main favorable prognostic factors are younger age, low/standard cytogenetic risk... View more
Share - Bookmark